| __timestamp | BioMarin Pharmaceutical Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 12402000000 |
| Thursday, January 1, 2015 | 634806000 | 17449000000 |
| Friday, January 1, 2016 | 661905000 | 17834000000 |
| Sunday, January 1, 2017 | 610753000 | 19551000000 |
| Monday, January 1, 2018 | 696328000 | 18265000000 |
| Tuesday, January 1, 2019 | 715007000 | 15607000000 |
| Wednesday, January 1, 2020 | 628116000 | 15410000000 |
| Friday, January 1, 2021 | 628793000 | 16541000000 |
| Saturday, January 1, 2022 | 649606000 | 17482000000 |
| Sunday, January 1, 2023 | 746773000 | 19381000000 |
| Monday, January 1, 2024 | 747184000 | 22873000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc. have demonstrated distinct strategies in their R&D investments. Dr. Reddy's Laboratories, based in India, has consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $19.4 billion in 2023, marking a 56% increase since 2014. In contrast, BioMarin, a leader in rare disease therapies, has shown a steady yet more modest growth in R&D spending, reaching around $747 million in 2023, a 62% rise from 2014. This divergence highlights the varied approaches these companies take in driving innovation and maintaining competitive edges in their respective markets. Notably, data for BioMarin in 2024 is unavailable, suggesting potential shifts in strategy or reporting.
R&D Spending Showdown: Zoetis Inc. vs Dr. Reddy's Laboratories Limited
Who Generates More Revenue? Dr. Reddy's Laboratories Limited or BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs BioMarin Pharmaceutical Inc.
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Perrigo Company plc
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alkermes plc
BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Travere Therapeutics, Inc.
BioMarin Pharmaceutical Inc. or Evotec SE: Who Invests More in Innovation?